Journal Mobile Options
Table of Contents
Vol. 27, No. 4, 1983
Issue release date: 1983
Add to my selection Citation Download
Ann Nutr Metab 1983;27:320–327
(DOI:10.1159/000176693)
Paper

Iron Supplements versus Placebo during Pregnancy: Its Effects on Iron and Folate Status on Mothers and Newborns

Zittoun J.a · Blot I.b · Hill C.c · Zittoun R.a · Papiernik E.b · Tchernia G.b
aService Central d’Hématologie-Immunologie (Prof. C. Sultan), Hôpital Henri-Mondor, Créteil et Hôtel-Dieu, Paris; bService d’Obstétrique et Laboratoire d’Hématologie, Hôpital Antoine-Beclère, Clamart; cUnité de Recherches Statistiques de l’Inserm (U-21) et Département de Statistique Médicale de l’Institut Gustave-Roussy, Villejuif, France Ann Nutr Metab 1983;27:320–327 (DOI:10.1159/000176693)

Abstract

Iron and folate status of 203 pregnant women have been evaluated at 6 months gestation and on the same women and their newborn infants at delivery. The women who had, at 6 months gestation, a Hb level below 11 g/dl were systematically given iron supplements. Iron or placebo were randomly allocated to the other women. At 6 months of pregnancy, one quarter of the women had a Hb level under 11 g/dl but one third had a serum ferritin level below 12 μg/l and more than half had low levels of serum and red cell folate. Iron supplements induced an increase both in Hb levels and in serum ferritin values; however, no significant differences were observed in serum ferritin of the newborn infants, whether their mothers had received iron supplements or not. These results have led us to reconsider the value of ferritin levels at birth as an index of iron stores in the infant. Iron supplements had no effect on the folate status in mothers or infants or on the frequency of obstetrical complications. A significant relationship was found between maternal folate levels and length of gestation. Folate supplementation may reduce the incidence of premature delivery.

 goto top of outline Author Contacts

Dr. Jacqueline Zittoun, Service Central d’Hématologie-Immunologie, Hôpital Henri-Mondor, F-94010 Créteil (France)


 goto top of outline Article Information

Received: June, 7, 1982
Accepted: September, 10, 1982
Published online: November 18, 2008
Number of Print Pages : 8


 goto top of outline Publication Details

Annals of Nutrition and Metabolism (Journal of Nutrition, Metabolic Diseases and Dietetics)

Vol. 27, No. 4, Year 1983 (Cover Date: 1983)

Journal Editor: Elmadfa I. (Vienna)
ISSN: 0250–6807 (Print), eISSN: 1421–9697 (Online)

For additional information: http://www.karger.com/ANM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.